Brown Spencer D. 4
4 · PDS Biotechnology Corp · Filed Jul 25, 2025
Insider Transaction Report
Form 4
Brown Spencer D.
Senior VP, General Counsel
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-02-28+56,000→ 56,000 totalExercise: $5.87Exp: 2034-02-28→ Common Stock (56,000 underlying) - Award
Employee Stock Option (Right to Buy)
2025-06-12+150,000→ 150,000 totalExercise: $1.79Exp: 2035-06-12→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- [F2]The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.